Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Parapharyngeal Metastasis of an Occult Thyroid Carcinoma
Journal Information
Vol. 95. Issue 1.
Pages 44 (January 2017)
Vol. 95. Issue 1.
Pages 44 (January 2017)
Image of the month
DOI: 10.1016/j.cireng.2016.01.003
Full text access
Parapharyngeal Metastasis of an Occult Thyroid Carcinoma
Met??stasis parafar??ngea de carcinoma oculto de tiroides
Visits
...
Arancha Garc??a L??pez, Mar??a D. Balsalobre Salmeron
Corresponding author
mariadolores.balsalobre2@um.es

Corresponding author.
, Mar??a Jos?? Carrillo
Hospital Universitario Santa Luc??a, Cartagena, Murcia, Spain
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

A 36-year-old patient presented with dysphagia and cough. His medical history of interest included total thyroidectomy for multinodular goiter three years earlier. A cervical computed tomography scan demonstrated a nodule measuring 3.4cm in the parapharyngeal space (Fig. 1). Fine needle aspiration revealed metastasis of papillary carcinoma. An I131 scan confirmed a single uptake in that area, while lab work revealed a thyroglobulin level of 4.9ng/mL. The parapharyngeal mass was resected, and the histopathological study demonstrated papillary carcinoma metastasis. Stimulated thyroglobulin levels were normal 3 months later.

Fig. 1
(0.11MB).

Single lymph node metastases of thyroid cancer in the retropharyngeal and parapharyngeal spaces are very rare. They are due to the migration of cells through the direct lymphatic drainage pathway, as described by Rouvière.

Please cite this article as: García López A, Balsalobre Salmeron MD, Carrillo MJ. Metástasis parafaríngea de carcinoma oculto de tiroides. Cir Esp. 2017;95:44.

Copyright © 2016. AEC
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos